Stocks Health care PDSB

NASDAQ · Health care

PDS Biotechnology Corp (PDSB)

It posted a net loss of $33.7M. In fiscal 2025 capital spending exceeded operating cash flow by $27.8M. At June 30, 2026 it held $5.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

What PDS Biotechnology Corp does

PDS Biotechnology Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PDSB.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What PDS Biotechnology Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 22, 2026
   Other event 8-K
2. September 21, 2026
   Activist stake (5% or more) SCHEDULE 13D
3. September 21, 2026
   Other event 8-K
4. September 14, 2026
   Executive or director change 8-K
5. September 8, 2026
   Material agreement 8-K
6. September 4, 2026
   Material agreement 8-K
7. August 25, 2026
   Executive or director change 8-K
8. August 19, 2026
   Executive or director change 8-K
9. August 14, 2026
   Bylaws or fiscal year changed 8-K
10. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.18 versus -$0.21.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 21, 2026. Insider transactions on SEC

Who owns PDSB

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PDSB

What does PDS Biotechnology Corp do?

PDS Biotechnology Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PDSB.

Is PDS Biotechnology Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $33.7M.

When did PDS Biotechnology Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 22, 2026.

Similar companies

Compare PDSB with

Compare PDSB with any company

Follow PDSB

Get an email when PDS Biotechnology Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow PDSB: get an email when it files

Where the numbers come from

Financial figures are the values PDS Biotechnology Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.